Loading ROIV…
SEC filing
ROIV · CIK 1635088
4 · Aug 24, 2026 · President & Immunovant CEO Venker Eric reported 13.91K Common Shares
President & Immunovant CEO Venker Eric reported 13.91K Common Shares
FORM 4
Graphics and non-inline formats (not embedded below).